What amount sold does RxE2 Inc. report in Form D filings?

The latest linked filings report $2M sold across 3 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was RxE2 Inc.'s most recent SEC filing?

RxE2 Inc.'s most recent Form D filing was on 2021-04-19.

What type of securities does RxE2 Inc. offer?

RxE2 Inc.'s SEC Form D filings indicate equity offerings.

RxE2 Inc.

CIK: 0001855833·Other·FARGO, ND·Corporation·Founded 2021

Reported Sold

$2,000,001

Total Filings

Identified Offerings

Last Filed

Apr 19, 2021

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Other industry

SEC EDGAR

Offering filing timeline

Apr 19, 2021Form D — New notice

Reported sold: $1 · Target: $1

Rule 506(b)·0 investors

Apr 19, 2021Form D — New notice

Reported sold: $0 · Target: $1

Rule 506(b)·0 investors

Apr 19, 2021Form D/A — Amendment

Reported sold: $2,000,000 · Target: $2,000,000

Rule 506(b)·0 investors

Changed: Reported amount sold, Offering target

Apr 8, 2021Form D — New notice

Reported sold: $1 · Target: $1

Rule 506(b)·4 investors

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

Amendment Rate

25%

Latest reported sold across 3 identified offerings

$2,000,001

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Gerald E. Finken

Related Person

Appears on 3 filings

Gerald Finken

Related Person

Appears on 1 filing

Filing History

Date	Type	Offering target	Reported sold	Investors
Apr 19, 2021	Amendment	$2,000,000	$2,000,000	0
Apr 19, 2021	New	$1	$0	0
Apr 19, 2021	New	$1	$1	0
Apr 8, 2021	New	$1	$1	4

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

Eat Scoops, Inc.

Other

Offering target: $1,855,680

Filed Nov 4, 2026